DeutschNewstral
Article
The New York Times on 2021-12-23 16:30
The F.D.A. cleared a second Covid pill, developed by Merck, offering another treatment for high-risk adults.
Related news
- The F.D.A. cleared a second Covid pill, developed by Merck, offering another treatment for high-risk adults.The New York Times
Merck COVID pill gains US clearance for high-risk adultsStar Telegram- Merck's Covid Pill Cleared by FDA for High-Risk AdultsThe New York Times
- The F.D.A. cleared Pfizer’s Covid pill, the first of its kind, for high-risk patients 12 and over.The New York Times
- F.D.A. Advisers Meets on Merck’s Covid PillThe New York Times
Merck forecasts covid-pill profitsArkansas Online- F.D.A. Clears Merck's Covid Pill for High-Risk AdultsThe New York Times
- CF.D.A. Authorizes Coronavirus Booster Shots for All Adultscentralrecorder.com
FDA finds Merck COVID-19 pill effectivebangordailynews.com- Merck Applies for F.D.A. Approval for First Antiviral Pill to Treat CovidThe New York Times
- Merck Applies for F.D.A. Clearance for First Antiviral Pill to Treat CovidThe New York Times
- FDA: Merck covid pill effective, experts will review safetyArkansas Online
FDA: Merck COVID pill effective, experts will review safetyocregister.com
FDA health panel endorses Merck COVID-19 pillisraelnationalnews.com
Merck COVID-19 pill: FDA panel weighs safety, effectivenessFox News
Merck pill for COVID-19 also gets federal approvaloregonlive.com- Merck asks U.S. FDA to authorize promising anti-covid pillArkansas Online